Sagimet Biosciences Inc (SGMT)
4.82
+0.12
(+2.55%)
USD |
NASDAQ |
May 24, 16:00
4.82
0.00 (0.00%)
After-Hours: 20:00
Sagimet Biosciences Cash and Short Term Investments (Quarterly): 193.70M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 193.70M |
| December 31, 2023 | 94.90M |
| September 30, 2023 | 101.84M |
| June 30, 2023 | 18.51M |
| Date | Value |
|---|---|
| March 31, 2023 | 25.25M |
| December 31, 2022 | 32.34M |
| March 31, 2021 | 74.94M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
18.51M
Minimum
Jun 2023
193.70M
Maximum
Mar 2024
77.36M
Average
74.94M
Median
Mar 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 1.059B |
| Viking Therapeutics Inc | 962.98M |
| 89bio Inc | 562.29M |
| Arrowhead Pharmaceuticals Inc | 523.11M |
| Akero Therapeutics Inc | 903.66M |